Yuan Cheng-Liang, Liu Zhao-Hong, Zou Ning, Wang Ya-Li, Chen Zhong-Yao
Department of Clinical Laboratory, Deyang People's Hospital, Deyang 618000, China.
Saudi J Biol Sci. 2017 Dec;24(8):1767-1770. doi: 10.1016/j.sjbs.2017.11.009. Epub 2017 Nov 10.
It is designed to discuss the relationship between the expression of chemokine receptor 7 (chemokine receptor 7, CXCR7) and nuclear transcription factor-κB (nuclear factor kappa B, NF-κB) and the occurrence of the breast cancer and lymphatic metastasis.
80 samples were excised and confirmed as breast cancer through our hospital pathology from January 2014 to December 2016 and tumor tissues and normal mammary tissues 2 cm from the tumor edges were taken as an experimental group and a control group, respectively. The method of immunohistochemical is utilized to test the expression of CXCR7 and NF-κB in the breast cancer tissue, compared with the para-carcinoma tissue, and analyze its relevance with the clinicopathologic features of the breast cancer tissue, such as tumor size, TNM staging, lymphatic metastasis and other conditions.
both CXCR7 and NF-κB were highly expressed in the breast cancer tissue, the positive rate was significantly higher that that of paracancerous normal tissues, and the difference was statistically significant. And the expressions of CXCR7 and NF-κB were related to TNM staging of the breast cancer and lymphatic metastasis and unrelated to the tumor size, age, and expressions of ER, PR and HER2.
both CXCR7 and NF-κB are related to the malignant grade of the breast cancer and lymphatic metastasis, which may be regarded as in important indicator to judge the prognosis of the breast cancer and be expected to be the new target of curing part of the breast cancer.
旨在探讨趋化因子受体7(chemokine receptor 7,CXCR7)与核转录因子-κB(nuclear factor kappa B,NF-κB)的表达与乳腺癌发生及淋巴转移的关系。
选取2014年1月至2016年12月在我院病理确诊为乳腺癌的80例样本,分别取肿瘤组织及距肿瘤边缘2 cm的正常乳腺组织作为实验组和对照组。采用免疫组化方法检测乳腺癌组织中CXCR7和NF-κB的表达,并与癌旁组织进行比较,分析其与乳腺癌组织临床病理特征如肿瘤大小、TNM分期、淋巴转移等情况的相关性。
CXCR7和NF-κB在乳腺癌组织中均高表达,阳性率显著高于癌旁正常组织,差异有统计学意义。且CXCR7和NF-κB的表达与乳腺癌的TNM分期及淋巴转移有关,与肿瘤大小、年龄以及ER、PR和HER2的表达无关。
CXCR7和NF-κB均与乳腺癌的恶性程度及淋巴转移有关,可作为判断乳腺癌预后的重要指标,有望成为部分乳腺癌治疗的新靶点。